Search research articles
Contact Us
Filters
Showing results (281-290 of 298) with videos related to
Page
of 30
Sort By:
JHEP Reports : Innovation in Hepatology
|
May 1, 2026
Clinical features and management for CDK4/6 inhibitor-DILI
Mar Riveiro-Barciela, Paula Esteban, Kreina Sharela Vega-Cano, et al.
Revista Espanola De Enfermedades Digestivas
|
December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Joaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Hepatology (Baltimore, Md.)
|
July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cure
Georg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology
|
March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.
Journal of Clinical Microbiology
|
November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods
Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 298) with videos related to
Sort By:
Page
of 30
JHEP Reports : Innovation in Hepatology
|
May 1, 2026
Clinical features and management for CDK4/6 inhibitor-DILI
Mar Riveiro-Barciela, Paula Esteban, Kreina Sharela Vega-Cano, et al.
Revista Espanola De Enfermedades Digestivas
|
December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Joaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Hepatology (Baltimore, Md.)
|
July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology
|
September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cure
Georg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology
|
March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Georg Semmler, Sonia Alonso López, Monica Pons, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.
Journal of Clinical Microbiology
|
November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods
Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Page
of 30